Blogs for April 2022

Hypoxia-Dependent CAR Stabilizing Construct in T cells Improves Solid Tumor Targeting and Efficacy

Monday, April 11, 2022 - 08:54
Banner image showing a chimeric antigen receptor (CAR) T cell.

By Victoria Osinski, PhD

Despite advances in the development of cancer immunotherapies, those specifically targeting tumors still remains limited. Currently, there is great interest in utilizing chimeric antigen receptor (CAR) T cell therapies: a strategy that utilizes patients’ T cells and genetically engineers them to produce a T cell receptor to mount an attack against cancer cells. While CAR T cells can effectively kill cancer cells in tumors, they often come with off-tumor effects because these CARs’ target antigens are found endogenously in the body....


Blog Topics


Archives